{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:31:25Z","timestamp":1791070285666,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21_supplement_1","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2013,11,19]]},"DOI":"10.1212\/01.wnl.0000435743.49414.b6","type":"journal-article","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T21:16:57Z","timestamp":1384809417000},"update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":56,"title":["Achieving consensus for clinical trials"],"prefix":"10.1212","volume":"81","author":[{"given":"Scott R.","family":"Plotkin","sequence":"first","affiliation":[{"name":"From the Neurology Department and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston, MA; Department of Neurology, Neurosurgery, and Oncology (J.O.B.), Johns Hopkins, Baltimore, MD; Pediatric Oncology Branch (E.D., P.L.W., B.C.W.), National Cancer Institute, Bethesda, MD; Division of Oncology, Department of Pediatrics (M.J.F.), The Children's Hospital of Pennsylvania, Philadelphia; Plymouth University Peninsula Schools of Medicine and Dentistry (C.O.H.), Plymouth, United Kingdom; and The..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishri O.","family":"Blakeley","sequence":"additional","affiliation":[{"name":"From the Neurology Department and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston, MA; Department of Neurology, Neurosurgery, and Oncology (J.O.B.), Johns Hopkins, Baltimore, MD; Pediatric Oncology Branch (E.D., P.L.W., B.C.W.), National Cancer Institute, Bethesda, MD; Division of Oncology, Department of Pediatrics (M.J.F.), The Children's Hospital of Pennsylvania, Philadelphia; Plymouth University Peninsula Schools of Medicine and Dentistry (C.O.H.), Plymouth, United Kingdom; and The..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Dombi","sequence":"additional","affiliation":[{"name":"From the Neurology Department and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston, MA; Department of Neurology, Neurosurgery, and Oncology (J.O.B.), Johns Hopkins, Baltimore, MD; Pediatric Oncology Branch (E.D., P.L.W., B.C.W.), National Cancer Institute, Bethesda, MD; Division of Oncology, Department of Pediatrics (M.J.F.), The Children's Hospital of Pennsylvania, Philadelphia; Plymouth University Peninsula Schools of Medicine and Dentistry (C.O.H.), Plymouth, United Kingdom; and The..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Fisher","sequence":"additional","affiliation":[{"name":"From the Neurology Department and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston, MA; Department of Neurology, Neurosurgery, and Oncology (J.O.B.), Johns Hopkins, Baltimore, MD; Pediatric Oncology Branch (E.D., P.L.W., B.C.W.), National Cancer Institute, Bethesda, MD; Division of Oncology, Department of Pediatrics (M.J.F.), The Children's Hospital of Pennsylvania, Philadelphia; Plymouth University Peninsula Schools of Medicine and Dentistry (C.O.H.), Plymouth, United Kingdom; and The..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Oliver","family":"Hanemann","sequence":"additional","affiliation":[{"name":"From the Neurology Department and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston, MA; Department of Neurology, Neurosurgery, and Oncology (J.O.B.), Johns Hopkins, Baltimore, MD; Pediatric Oncology Branch (E.D., P.L.W., B.C.W.), National Cancer Institute, Bethesda, MD; Division of Oncology, Department of Pediatrics (M.J.F.), The Children's Hospital of Pennsylvania, Philadelphia; Plymouth University Peninsula Schools of Medicine and Dentistry (C.O.H.), Plymouth, United Kingdom; and The..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin S.","family":"Walsh","sequence":"additional","affiliation":[{"name":"From the Neurology Department and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston, MA; Department of Neurology, Neurosurgery, and Oncology (J.O.B.), Johns Hopkins, Baltimore, MD; Pediatric Oncology Branch (E.D., P.L.W., B.C.W.), National Cancer Institute, Bethesda, MD; Division of Oncology, Department of Pediatrics (M.J.F.), The Children's Hospital of Pennsylvania, Philadelphia; Plymouth University Peninsula Schools of Medicine and Dentistry (C.O.H.), Plymouth, United Kingdom; and The..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Wolters","sequence":"additional","affiliation":[{"name":"From the Neurology Department and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston, MA; Department of Neurology, Neurosurgery, and Oncology (J.O.B.), Johns Hopkins, Baltimore, MD; Pediatric Oncology Branch (E.D., P.L.W., B.C.W.), National Cancer Institute, Bethesda, MD; Division of Oncology, Department of Pediatrics (M.J.F.), The Children's Hospital of Pennsylvania, Philadelphia; Plymouth University Peninsula Schools of Medicine and Dentistry (C.O.H.), Plymouth, United Kingdom; and The..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte C.","family":"Widemann","sequence":"additional","affiliation":[{"name":"From the Neurology Department and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston, MA; Department of Neurology, Neurosurgery, and Oncology (J.O.B.), Johns Hopkins, Baltimore, MD; Pediatric Oncology Branch (E.D., P.L.W., B.C.W.), National Cancer Institute, Bethesda, MD; Division of Oncology, Department of Pediatrics (M.J.F.), The Children's Hospital of Pennsylvania, Philadelphia; Plymouth University Peninsula Schools of Medicine and Dentistry (C.O.H.), Plymouth, United Kingdom; and The..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70075-3"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-4-16"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0162"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000042321.94839.78"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24281"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000243231.12248.67"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2011-100562"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1993.01680260047004"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.10.1461"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.8638"},{"key":"e_1_3_7_14_2","unstructured":"Widemann B Dombi E Gillespie A et al.. Phase II randomized flexible cross-over double-blinded placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in pediatric patients with NF1 and progressive plexiform neurofibromas. Presented at Children's Tumor Foundation Conference; June 2009. Abstract."},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2007.01.009"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.3.287"},{"key":"e_1_3_7_17_2","first-page":"451","article-title":"Results of COG protocol A9952- a randomized phase 3 study of two chemotherapy regimens for incompletely resected low-grade glioma in young children","volume":"10","author":"Ater J","year":"2008","unstructured":"Ater J, Holmes E, Zhou T, et al.. Results of COG protocol A9952- a randomized phase 3 study of two chemotherapy regimens for incompletely resected low-grade glioma in young children. Neuro-oncol 2008;10:451. Abstract.","journal-title":"Neuro-oncol"},{"key":"e_1_3_7_18_2","unstructured":"Weiss B Fisher M Dombi E et al.. Phase II study of the mTOR inhibitor sirolimus for non-progressive NF1-associated plexiform neurofibromas: a Neurofibromatosis Consortium Study. Presented at 14th International Symposium on Pediatric Neuro-Oncology Abstract Book 2010; ii43. Abstract."},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2011.06.016"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318207b031"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos146"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70414-X"},{"key":"e_1_3_7_23_2","article-title":"Feasibility of photodynamic therapy using intratumoral light in children with neurofibromatosis type 1 and plexiform neurofibromas","volume":"14","author":"Fisher MJ","year":"2012","unstructured":"Fisher MJ, Meyer J, Roberts T, et al.. Feasibility of photodynamic therapy using intratumoral light in children with neurofibromatosis type 1 and plexiform neurofibromas. Neuro-oncol 2012;14. i18.Abstract.","journal-title":"Neuro-oncol"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/01.wnl.0000435743.49414.b6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T12:49:49Z","timestamp":1711630189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/01.wnl.0000435743.49414.b6"}},"subtitle":["The REiNS International Collaboration"],"short-title":[],"issued":{"date-parts":[[2013,11,19]]},"references-count":22,"journal-issue":{"issue":"21_supplement_1","published-print":{"date-parts":[[2013,11,19]]}},"alternative-id":["10.1212\/01.wnl.0000435743.49414.b6"],"URL":"https:\/\/doi.org\/10.1212\/01.wnl.0000435743.49414.b6","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,19]]}}}